MDGL (Madrigal Pharmaceuticals) Rega marang bathi mangsa ngarep

Lambang korporat lan logo Madrigal Pharma (MDGL)

The forward P/E chart for Madrigal Pharmaceuticals (MDGL) reflects market expectations, where a metric value of 60.70 is driven by its first-mover status in NASH therapy and potential for high margins. High barriers to entry and patent protection create a robust moat against competitors. The business is currently focusing on the large-scale deployment of the distribution network for its primary drug within the US region.

MDGL - Rasio prakiraan rega marang bathi Madrigal Pharmaceuticals Inc ing rentang 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Madrigal Pharmaceuticals

- rega saiki lan proyeksi nilai saham:
Analisis umum perusahaan:MDGL madrigalpharma.com
Produk merek Madrigal Corp

The resilience of Madrigal Pharmaceuticals (MDGL) is based on the monopoly status of the first drug for the therapy of nonalcoholic steatohepatitis. The company's expected P/E multiple visualizes market expectations for the commercialization of this asset. This indicator is calculated by dividing the current quote by the projected net income. This metric measures investors' willingness to pay a premium for future revenue growth. A decrease in the ratio signals that the business is undervalued relative to its fundamental prospects.

Pesaing Madrigal Pharmaceuticals (MDGL)

Prakiraan rega marang bathi ASND (Ascendis Pharma Inc.)|CORT (Corcept Therapeutics Corp) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep rhythmtx.com RYTM|AKRO - Prakiraan rega marang bathi|Metsera Therapeutics - Pangali Forward P/E|Rasio prakiraan rega marang bathi MoonLake Pharma|CRNX (Crinetics) - Prakiraan rega marang bathi|NAMS: Rasio kapitalisasi marang bathi mangsa ngarep|SLNO (Soleno Therapeutics Corp) - Pangali Forward P/E|Pangali Forward P/E Amicus Therapeutics|Pangali Forward P/E ETNB|Rega marang bathi mangsa ngarep AGIO (Agios)|Rega marang bathi mangsa ngarep structuretx.com GPCR|MiMedx Corp (MDXG) - Rasio prakiraan rega marang bathi|RZLT - Rega marang bathi mangsa ngarep|LXRX: Rega marang bathi mangsa ngarep|MBX Biosciences, Inc. (MBX) - Rega marang bathi mangsa ngarep|ALT - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Aardvark Pharma|Sagimet Biosciences Inc (SGMT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep bioagelabs.com (BIOA)|Prakiraan rega marang bathi Biomea Fusion, Inc. BMEA|Rega marang bathi mangsa ngarep Quince QNCX|GUTS (Fractyl Health Inc.) - Rasio rega marang bathi sing dikarepake|VTVT: Prakiraan rega marang bathi|Pangali forward rega marang bathi agapeatpgroup.com (ATPC)|PLUR (Pluri) - Prakiraan rega marang bathi|Rasio rega marang bathi mangsa ngarep SYBX|Rega marang bathi mangsa ngarep Lipocine Corporation|matinasbiopharma.com (MTNB) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SPRB|Prakiraan rega marang bathi Galecto, Inc. GLTO|Rega marang bathi mangsa ngarep Carmell Corporation CTCX|Pangali mangsa ngarep rega marang bathi LUMO|ONVO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi RDUS (Radius Recycling Inc.)